A Single Ascending Dose Study Examining the Safety and Pharmacokinetic Profile of Reconstituted High Density Lipoprotein (CSL112) Administered to Patients

Clinical trial NCT01499420 · COMPLETED

Trial details

NCT number: NCT01499420
Sponsor: CSL Limited
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Stable Atherothrombotic Disease

Start date: 2012-02-01
Primary completion: 2012-12-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.